BioSpace News Archive

Entera Bio Ltd., announced that it will report financial results for the third quarter and nine months ended September 30, 2019 before the U.S. financial markets open on Thursday, November 21, 2019..

Checkpoint Therapeutics, Inc. announced financial results and recent corporate highlights for the third quarter ended September 30, 2019.

Company to host conference call on Monday, November 11, 2019 at 4:30pm EST to discuss current HBV landscape and update on the company’s development programs

Titan Pharmaceuticals, Inc. will announce its third quarter 2019 financial results after market close on Thursday, November 14, 2019. Following the release, Titan management will host a conference call at 4:30 p.m. EST / 1:30 p.m. PST to review the financial results and discuss business developments in the period.

22nd Century Builds Strong Momentum for its Very Low Nicotine Content Tobacco and Makes Significant Progress in the Development of Valuable New Hemp/Cannabis Plants

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the third quarter ended September 30, 2019.

ERYTECH Pharma,a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided a business update and reported its financial results for the quarter ended September 30, 2019.

Stemline Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, reported financial results and business highlights for the third quarter ended September 30, 2019.

IGM Biosciences, Inc. announced its financial results for the third quarter ended September 30, 2019 and provided an update on recent developments.

CRH Medical Corporation, announced financial and operating results for the three months ended September 30, 2019..